KLK1
protein-codingkallikrein 1, the group of Kallikreins
Gene summary
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. This gene is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. This protein is functionally conserved in its capacity to release the vasoactive peptide, Lys-bradykinin, from low molecular weight kininogen. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~4.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0015924
Submitter: ClinGen
*KLK1* was first reported in relation to autosomal dominant pulmonary arterial hypertension (PAH) in 2019 (Zhu et al., PMID: 31727138). Seven missense, one frameshift, one stop-gain, and one splice variant were identified in a case-control study. Ten probands were identified by exome sequencing of a large cohort from the National Biological Sample and Data Repository for PAH (n = 2572 cases). One variant was recurrent in two unrelated but affected individuals. The mechanism of pathogenicity was suggested to be loss of function. The *KLK1*-PAH relationship was supported by expression in adult lung (PMID: 17573418). In summary, the evidence for a gene-disease relationship between *KLK1* and autosomal dominant PAH is limited. This classification was approved by the ClinGen Pulmonary Hypertension GCEP on 8/30/2022 (SOP Version 9). The KLK1 gene-disease relationship was re-evaluated on 1/14/2026 by the ClinGen PH Gene Curation Expert Panel (SOP v11). No new genetic evidence was identified. The previously identified *KLK1* variants (Zhu et al., PMID: 31727138) were reevaluated according to updated PH GCEP thresholds for variant inclusion: AF <= 0.0001 in gnomAD 2.1.1 control subpopulations or absent from gnomAD 4.1 subpopulations AND loss of function variant OR missense variant meeting pathogenicity score thresholds for 2 out of 3 predictors (CADD>=25.3, REVEL>=0.644, AlphaMissense >=0.792 (missense variants). Two *KLK1* missense variants did not reach the thresholds for allele frequency or pathogenicity. No new experimental evidence was identified but PAH relevant expression was confirmed in lung cells using single cell RNA-seq data (PMID: 33915568). In summary, the evidence for a gene-disease relationship between *KLK1* and autosomal dominant PAH remains classified as limited. This classification was approved by the ClinGen Pulmonary Hypertension GCEP on 1/14/2026 (SOP Version 11).
Inheritance Pattern: AD
Disease ID:MONDO:0015924
Submitter: PanelApp Australia
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to KLK1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_002257.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 34 | 3 | 37 | |||
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 34 | 4 | 1 | 39 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_002248.1 | 5 | MANE Select | |
| Ensembl | ENSP00000301420.1 | 5 | MANE Select | |
| Ensembl | ENSP00000472939.1 | 3 | Standard | |
| Ensembl | ENSP00000548983.1 | 5 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Renin-angiotensin system - Homo sapiens (human)
- Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human)
- Blood Clotting Cascade
- Dengue-2 Interactions with Blood Clotting Cascade
- Metabolism of proteins
Biological Process
- regulation of systemic arterial blood pressure
- zymogen activation
Molecular Function
- serine-type endopeptidase activity
Cellular Component
- nucleus
- secretory granule
- extracellular exosome
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000301420
- Coding exons
- 5
- Length
- 4640
- Individuals with no LoFs
- 125705
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 41
- Defined
- 125746
- p
- 0.000163
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.443 | 138 | 153 | 0.899 | 0.00000793 | 1718 |
| Missense (PolyPhen) | 44 | 51.223 | 0.85899 | 617 | ||
| Synonymous | -1.19 | 77 | 64.8 | 1.19 | 0.00000368 | 514 |
| Loss of Function | 0.865 | 7 | 9.94 | 0.704 | 4.26e-7 | 104 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00011 | 0.00011 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00024 | 0.00024 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0.00033 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Glandular kallikreins cleave Met-Lys and Arg-Ser bonds in kininogen to release Lys-bradykinin.;
Recessive Scores
- pRec
- 0.420
Intolerance Scores
- LoFtool
- 0.401
- RVIS EVS
- 0.68
- RVIS percentile EVS
- 85.04
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.351
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |